FDA permits marketing of AI-based device to detect diabetic retinopathy
The FDA has permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy...
List view / Grid view
The FDA has permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy...
Scientists in California have undertaken studies that have demonstrated the effectiveness of a sophisticated algorithm in preventing the spread of infectious diseases. The application of AI allows authorities to identify the best use of resources and highlight subtle interaction points that might otherwise be missed.
Using AI and machine learning techniques, researchers have developed a new computational tool to screen patients with common retinal diseases, potentially speeding diagnoses and treatment...
Researchers have developed a new type of malleable, self-healing and fully recyclable "electronic skin" that has applications ranging from robotics and prosthetic development to better biomedical devices...
Researchers in the emerging field of neuromorphic computing have attempted to design computer chips that work like the human brain...
An ingredient commonly found in toothpaste could be employed as an anti-malarial drug against strains of the malaria parasite that have grown resistant to one of the currently used drugs...
The ability to quantify the extent of kidney damage and predict the life remaining in the kidney is now possible using a computer model based on artificial intelligence...
Using data on genetic material, cell surface texture and typical facial features, researchers have utilised artificial intelligence methods to simulate rare disease models...
The emergence of big data, technological innovations and advancements in scientific research is set to be transformative for the pharmaceutical industry, providing faster access to insights that can drive more informed decision making and accelerate drug development. Dr Chris Barber, CEO of Lhasa Limited, looks at what is next for…
NPL's new approach informed by government priorities, consultancy with industry and the NHS, and a century of expertise, will see it focus on some of the world’s biggest health challenges, from supporting the diagnosis and treatment of cancer and dementia, to reducing attrition rates in drug development, to creating new…
Scientists have used artificial intelligence capable of recognising the signatures of dementia two years before its onset...
Insilico Medicine develops the advanced artificial intelligence algorithms to study the ageing processes and discover new interventions in ageing...
Life Sciences and Healthcare supply chains need transformation to support the increasing cost pressures and consumer demands for new and more convenient, affordable care models…
A brain training game could help improve the memory of patients in the very earliest stages of dementia, suggests a study.
The EMA has approved Janssen's continuous manufacturing (CM) with real-time release testing for the production of Prezista (darunavir)...